Seven out of the 11 human cytidine deaminases are more highly expressed in tumor versus normal tissue and their higher expression is correlated with a decrease in survival. by Mason A. McCool (11889842)

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

Proteomic results: decreased. by Hongming Liu (631933)

“…<p>The proteins whose levels are decreased in CYP2E1 knockout versus wild type (WT) mice and directly related to carbohydrate, lipids, protein or amino acid catabolism, or biotransformation are listed. …”

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

A low dose of BTZ decreases proteasome activity with no effect on cell viability. by A. L. Furfaro (2587792)

CC-1⁺ immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

“…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1⁺ oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”

TLR2 activation increases MMP9 expression and decreases tropoelastin expression. by Stephanie E. Seidl (3812353)

Statistics of predicted bandgaps by SVR, GBDT, RF and MLP algorithms based on a 9-dimensional feature space. by Yu Zhang (12946)

Subjects:

GSK343 decreased neuroblastoma viability, proliferation, and motility. by Laura V. Bownes (10276762)

“…<p>(A) SK-N-AS, SK-N-BE(2), SH-EP and WAC(2) cells (1.5 × 10³ cells) were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and viability was measured using alamarBlue^® assay. …”

Thalidomide treatment inhibits growth in RAMEC but not in RAMEC transfected with a dominant negative mutant of CUL5 (^S730ACUL5) cDNA. by Bryan Kunkler (5204327)

V5-SgG2 transfection in the epidermis modifies the termination site of peptidergic FNE. by Jorge Rubén Cabrera (685511)

Decrease in the operational range of the enzymatic controller of Fig 51 (in dual-E control mode) as a function to decreased values of the forward enzymatic rate constants <i>k</i><... by Qaiser Waheed (5095328)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Excel spreadsheet containing, in separate sheets, the underlying numerical data and statistical analysis for Figs 1B, 1C, 1E, 1F, 1G, 2A, 2B, 3, 4B, 4C, 4D, 4E, 4F, 4G, 5A, 5B, 5C,... by Xi-Meng Sun (17721428)

Resveratrol decreases CYP17A1 and CYP21A2 protein expression. by Nesa Marti (3851059)

“…<p>A. Gene expression profiling by qRT-PCR was performed for CYP17, CYP21 and their cofactor POR in H295R cells grown under normal conditions (GM), starvation conditions (SM), metformin (Met) (1mM) treatment and under resveratrol (RSV) (5<u>μM)</u> treatment. …”

BH₄ bioavailability was decreased in cortical and hippocampal microvessels as compared to microvessels from the cerebellum. by Susan A. Austin (768265)

The average value of the aSCR for each condition and the AIC values for the five models considered. by Giulia Priolo (10146494)

Subjects:

Chronic Arachidonic Acid Administration Decreases Docosahexaenoic Acid- and Eicosapentaenoic Acid-Derived Metabolites in Kidneys of Aged Rats by Masanori Katakura (816112)

Subjects:

Distinct effects on calcium channel activation of <i>CACNA1I</i> disease-associated amino acid substitutions A398E/V and M1425V/I. by Yousra El Ghaleb (22075892)

Subjects:

Treatment with tnv-1 decreases growth of NSCLC cell lines. by Ivana Grbesa (730814)